---

$9.66

+0.3550 ( +5.52% ) 62.3K

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-12-31	Buy	30620.00	BAKER BROS. ADVISORS LP
2024-06-27	Sale	-4163.00	Reumuth Mary
2024-06-27	Sale	-15168.00	Iwicki Mark T
2024-06-27	Sale	-5489.00	Brazzell Romulus K
2024-06-27	Sale	-4653.00	Bazemore Todd
2024-06-27	Sale	-5158.00	Kharabi Darius
2024-06-12	Sale	-1400.00	PERRY GREGORY D
2024-06-12	Sale	-1400.00	Myers C. Daniel
2024-06-12	Sale	-1400.00	Farid Marjan
2024-06-12	Sale	-1750.00	KOVEN ANDREW I

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.